儿童脑部:连续暴露于大环状钆基对比剂后,齿状核在非增强T1加权MR图像上信号强度未增高
本研究回顾性纳入41例连续接受至少5次钆特酸葡胺增强检查的儿童患者,比较首次与末次非增强T1加权MR图像上齿状核与脑桥及小脑中脚的信号强度比值差,发现差异均与0无显著差异,贝叶斯因子提供反对信号增高的实质性证据,结论为未见齿状核信号强度增高。
要点
- 儿童连续接受大环状对比剂钆特酸葡胺后,齿状核与脑桥信号强度比值差为-0.0012±0.0101(P=.436),与0无显著差异。
- 齿状核与小脑中脚信号强度比值差为0.0007±0.0088(P=.604),与0无显著差异。
- 单侧贝叶斯因子分别为0.10(齿状核/脑桥)和0.27(齿状核/小脑中脚),为反对信号强度增高提供实质性证据。
核心结论
- 儿童患者平均连续注射8.6次大环状钆基对比剂钆特酸葡胺后,齿状核信号强度未见增高,与既往成人研究结果一致。
研究设计与样本
- 回顾性、经机构审查委员会批准的研究,纳入41例年龄3-17岁、连续至少5次1.5-T MR检查且仅使用钆特酸葡胺的儿童患者,并加做一次末次非增强MR检查。
诊断标准与关键数值
- 采用感兴趣区分析计算齿状核与脑桥比值及齿状核与小脑中脚比值的信号强度比值差,单样本t检验比较差值与0的差异,并计算贝叶斯因子;齿状核/脑桥比值差-0.0012±0.0101(P=.436),齿状核/小脑中脚比值差0.0007±0.0088(P=.604)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine the effect of at least five serial injections of the macrocyclic gadolinium-based contrast agent (GBCA) gadoterate meglumine on the signal intensity (SI) of the dentate nucleus (DN) of the pediatric brain on nonenhanced T1-weighted magnetic resonance (MR) images. Materials and Methods In this retrospective, institutional review board-approved study, 41 pediatric patients (age range, 3-17 years) who were imaged in at least five consecutive 1.5-T MR examinations with the exclusive use of gadoterate meglumine (plus a final additional nonenhanced MR imaging examination) were evaluated. SI ratio differences between the first and last MR examination were calculated for DN-to-pons and DN-to-middle cerebellar peduncle (MCP) ratios in a region-of-interest-based analysis, and one-sample t tests were used to examine if the SI ratio differences differed from 0. Bayes factors were calculated to quantify the strength of evidence for each test. Results Patients underwent a mean of 8.6 ± 3.9 GBCA administrations (mean accumulated dose, 32.07 mmol ± 17.62, with an average of 16.7 weeks ± 7.9 between every administration). Both ratio differences did not differ significantly from 0 (DN-to-pons ratio: -0.0012 ± 0.0101, P = .436; DN-to-MCP ratio: 0.0007 ± 0.0088, P = .604), and one-sided Bayes factors provided substantial evidence against an SI ratio increase (0.10 for DN-to-pons ratio; 0.27 for DN-to-MCP ratio). Conclusion No increase of the SI in the DN was found after a mean of 8.6 serial injections of the macrocyclic GBCA gadoterate meglumine in pediatric patients, confirming previous studies that did not find this effect after serial injections of macrocyclic GBCAs in adults. © RSNA, 2017.
引用
- Radbruch A, Haase R, Kickingereder P, et al. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent. Radiology. 2017. PMID: 28273007. doi:10.1148/radiol.2017162980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。